维普中文期刊产品整合服务
185篇 您的检索式:作者名="PRATLEY RE"
    题名 作者 年代 出处 被引量
1Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians显示文摘Weyer C Pratley RE 1999Obes Res1999,7,:2
2Improvements in blood pressures,glucose metabolism,and lipoprotein lipids after aerobic exercise plus weight loss in obess,hypertensive middle-aged men显示文摘Denge IDR Hagherg JM Pratley RE 1998Metabolism1998,47,8:1
3Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes:a randomized,double-blind,placebo-controlled study显示文摘Pratley RE Reusch JEB Fleck PR 2009Curr Med Res Opin2009,25,10:1
4Relationship between muscle sympathetic nerve activity and plasma leptin concentration显示文摘Snitker S Pratley RE Nicolson M 1997Obes Res1997,5,:1
5Efficacy and safety of initial combination therapy w ith alogliptin plus metformin versus either as monotherapy in drug-naive patients w eth type 2 diabetes:a randomized,double-blind,6-month study显示文摘Pratley RE Fleck P Wilson C 2014Diabetes Obes M etab2014,16,:1
6The role of inpaired early insulin secretion in the pathogenesis of Type Ⅱ diabetes mellitus 显示文摘Pratley RE Weyer C 2001Diabetologia2001,44,8:1
7Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glybufide monotherapy 显示文摘Pratley RE Kipnes MS Fleck PR 2009Diabetes Obes Metab2009,11,2:1
8Insulin receptor auto- phosphorylation in cultured myoblasLs correlates to glucose disposal ill Pima Indians 显示文摘Youngren JF Goldfine ID Pratley RE 1999Am J PlvsioL1999,276,39:1
9Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulinresistant Pima Indians显示文摘 Nicolson M Bogardus C 1997J Clin Endocrinol Metab1997,81,12:1
10Alogliptin use in elderly people: a pooled analysis from phase 2 and 3 studies 显示文摘Pratley RE McCall T Fleck PR 2009J Am Geriatr Soc2009,57,11:1
11Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes : a randomized, double-bfind, placebo- controlled study显示文摘Pratley RE Reusch JE Fleck PR 2009Curr Med Res Opin2009,25,10:1
12The evolving role of inflammation in obesity and the metabolic syndrome 显示文摘Lee YH Pratley RE 2005Curr Diab Rep2005,5,1:1
13Efficacy and safety of incretin - based thera- pies in patients with type 2 diabetes mellitus 显示文摘Gilbert MP Pratley RE 2009Eur J Intern Med2009,20,2:1
14Metabolic characteristics of individuals with impaired facting glucose and/or impaired glucosetolerance 显示文摘Weyer C Bogardus C Pratley RE 1999Diabetes1999,48,11:1
15Adding liraglutide to existing therapy rather than substituting it for existing therapy produees greater improvement in glycemic control: evidence from a meta-analusis 显示文摘Nauck MA Pratley RE Falahati A 2009Diabetes2009,58,:1
16Robust improvements in fasting and prandial measures of B-cell function with vidagliptin in drug-native patients:analysis of pooled vidagliptin monotherapy database显示文摘Pratley RE Schweizer A Rosenstock J 2008Diabetes Obes Metab2008,10,:1
17Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycae mic control with metformin: a 26 - week, randomised, parallel group ,open - label trial显示文摘Pratley RE Nauck M Bailey T 2010Lancet2010,375,:1
18Adipose tissue dysfunction in polycystic ovary syndrome显示文摘Villa J Pratley RE 2011Curr Diab Rep2011,11,3:1
19Inhibition of DPP-4 : a new therapeutic ap- proach for the treatment of type 2 diabetes显示文摘Pratley RE Salsali A 2007CmT Med ties Opin2007,23,4:1
20Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance 显示文摘Weyer C Bogardus C Pratley RE 1999Diabetes1999,48,:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费